aod9604 igf-1 effects AOD 9604 – The Fat-Burning Peptide: Benefits, Mechanism & Safety AOD-9604 vs MOTS-c vs Tesamorelin
Description
The 3.0 mL fill gives ~3.33 mg/mL, so 1 unit 33.3 mcg on a U-100 syringe (150 mcg = 4.5 units, 600 mcg = 18 units)
Metabolic Pharmaceuticals ultimately did not pursue Phase 3 trials for obesity, and the company's pipeline shifted toward other indications
Results depend heavily on baseline body composition, dietary adherence, exercise programming, sleep quality, stress management, genetic factors, and protocol compliance
How should I store my peptides
